[PDF][PDF] 中国胃癌筛查与早诊早治指南(2022, 北京)

赫捷, 陈万青, 李兆申, 李霓, 任建松, 田金徽… - 中国 …, 2022 - xadxyylib.yuntsg.com
胃癌是我国常见的恶性肿瘤之一, 严重威胁我国居民生命健康. 胃癌高风险人群接受筛查和早诊
早治能够有效降低胃癌的发病率和死亡率. 制定符合中国国情的胃癌筛查与早诊早治指南 …

Immunotherapy in advanced gastric cancer, is it the future?

C Coutzac, S Pernot, N Chaput, A Zaanan - Critical reviews in oncology …, 2019 - Elsevier
The prognosis of advanced gastric cancer remains extremely poor despite the use of
standard therapies such as chemotherapy and biological agents. Blocking immune …

Role of staging laparoscopy for gastric cancer patients

T Fukagawa - Annals of gastroenterological surgery, 2019 - Wiley Online Library
Staging laparoscopy (SL) is frequently carried out in patients with advanced gastric cancer.
However, some clinical questions are being debated and consensus must be obtained. With …

Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: current knowledge and future perspectives

J Palle, A Rochand, S Pernot, C Gallois, J Taïeb… - Drugs, 2020 - Springer
The discovery of human epidermal growth factor receptor 2 (HER2) overexpression in 15–
20% of gastric adenocarcinomas has been a key advance in the global care of this disease …

Serum cytokines and neutrophil-to-lymphocyte ratio as predictive biomarkers of benefit from PD-1 inhibitors in gastric cancer

Y Hou, X Li, Y Yang, H Shi, S Wang, M Gao - Frontiers in immunology, 2023 - frontiersin.org
Background Immunotherapy is significantly revolutionizing cancer treatment and
demonstrating promising efficacy in gastric cancer (GC) patients. However, only a subset of …

Current status and future perspectives in HER2 positive advanced gastric cancer

G Roviello, M Catalano, LF Iannone, L Marano… - Clinical and …, 2022 - Springer
Gastric cancer is one of the most common malignancy worldwide with a prognosis less than
1 year in unresectable or metastatic disease. HER2 expression is the main biomarker to …

II Brazilian consensus on gastric cancer by the Brazilian Gastric Cancer Association

LC Barchi, MFKP Ramos, AR Dias… - … Brasileiros de Cirurgia …, 2020 - SciELO Brasil
Background: Since the publication of the first Brazilian Consensus on Gastric Cancer (GC) in
2012 carried out by the Brazilian Gastric Cancer Association, new concepts on diagnosis …

Current evidence for the use of HIPEC and cytoreductive surgery in gastric cancer metastatic to the peritoneum

AJ Jain, BD Badgwell - Journal of Clinical Medicine, 2023 - mdpi.com
Simple Summary Advanced gastric cancer (GCa) is associated with poor prognosis due to
the challenge of peritoneal disease, the most common site of metastasis at initial diagnosis …

LncRNA SNHG8 promotes proliferation and invasion of gastric cancer cells by targeting the miR-491/PDGFRA axis

P Zhang, S Li, Z Chen, Y Lu, H Zhang - Human cell, 2020 - Springer
This study aimed to investigate the effects of long non-coding small nucleolar RNA host
gene 8 (SNHG8) on the proliferation and invasion of gastric cancer (GC). The GC tissues …

Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study)

PE Bonnot, A Lintis, F Mercier… - British Journal of …, 2021 - academic.oup.com
Background The incidence of gastric poorly cohesive carcinoma (PCC) is increasing. The
prognosis for patients with peritoneal metastases remains poor and the role of cytoreductive …